ArticleCureus2023

Guillain-Barre Syndrome Secondary to the Use of Dabrafenib and Trametinib for the Treatment of Advanced Thyroid Carcinoma.

Jaskaran Batra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.